Risk Factors of Hepatitis C Virus Transmission

  • Maimoona Maheen
  • Mehak Ruqia
  • Sana Fatima
Keywords: Hepatitis C, risk factors, surgery, blood transfusion, dental treatment.

Abstract

Background: Hepatitis C is not only a globally prevalent disease but also a significant cause of death. It has multiple complications ranging from Hepatocellular carcinoma to decompensated liver disease. This study was planned to determine the frequencies of various risk factors in Hepatitis C positive patients presenting to a tertiary care health facility in Rawalpindi.
Materials and Methods: This descriptive, cross-sectional study included 394 patients that presented to Liver Centre, Holy Family Hospital during the years 2015 to 2016. All these patients were confirmed cases of Hepatitis C. The data were collected from records of the liver center of Holy Family Hospital, Rawalpindi. Statistical Package for Social Sciences (SPSS), version 23 was used to analyze data, and descriptive statistics were calculated. All patients with any other comorbidity were excluded.
Results: Of the 394 patients included in this study, 197 (50%) males and 197(50%) females with an average age of 44.48. Out of these, 143(36.3%) had a history of previous surgery, 65 (16.5%) had a blood transfusion, 165 (42.19%) had a history of dental treatment, and 189(48.0%) had a history of injections (IM and IV). Ninety-two patients (23.4%) had a history of barber shave, four patients (1%) had tattooed, and 83 patients (21.1 %) had a history of ear piercing. Fifty patients (38.2%) had a family history of Hepatitis C. Only 23 (31.2%) patients had only one risk factor, while 271 (68.7%) had more than one risk factor before a diagnosis of disease.
Conclusion: The majority of the patients had more than one risk factor, with a history of injection use being the most common (intravenous and intramuscular). It was followed by the history of dental treatment, family history, and history of previous surgery.

References

[1] Mohamed AA, Elbedewy TA, Serafy ME, Toukhy NE, Ahmed W , El Din ZA. Hepatitis C virus: A global view. World J Hepatol. 2015 Nov 18;7(26):2676-2680.
[2] Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of hepatology. 2006 Oct 1;45(4):529-38
[3] Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age‐specific antibody to HCV seroprevalence. Hepatology. 2013 Apr;57(4):1333-42.
[4] Razjou F, Maghsudlu M, Nasizadeh S, Zadsar M. The impact of donor selection on blood safety in Iran. Transfusion and Apheresis Science. 2012 Aug 1;47(1):13-6.
[5] ang TJ. Current progress in development of hepatitis C virus vaccines. Nature medicine. 2013 Jul;19(7):869-78..
[6] Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. The Lancet. 2011 Aug 13;378(9791):571-83.
[7] Coury-Cautilena C, Van Raden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, Di Bisceglie A, Hoofnagle J, Shih JW, Kaslow R. Routes of infection, viremia, and liver disease in asymptomatic individuals with hepatitis C virus infection. N Engl J Med. 1996;334:1691-6.
[8] Koerner K, Cardoso M, Dengler TH, Kerowgan M, Kubanek B. Estimated risk of transmission of hepatitis C virus by blood transfusion. Vox Sanguinis. 1998;74(4):213-6.
[9] Tillmann HL, Manns MP. Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups. Digestive diseases and sciences. 1996 Dec 1;41(12):27S-40S.
[10] CfDC CD. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity Mortality Weekly Rep. 1998 Oct 16;47:139.
[11] MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: rates, routes, and cofactors. Epidemiologic reviews. 1996 Jan 1;18(2):137-48.
[12] Alter MJ, Hadler SC, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Moyer LA, Fields HA, Bradley DW, Margolis HS. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. Jama. 1990 Nov 7;264(17):2231-5.
[13] Hutin YJ, Hauri AM, Armstrong GL. Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. Bmj. 2003 Nov 6;327(7423):1075.
[14] Janjua NZ, Hutin YJ, Akhtar S, Ahmad K. Population beliefs about the efficacy of injections in Pakistan's Sindh province. Public health. 2006 Sep 1;120(9):824-33.
[15] Cooke GS, Lemoine M, Thursz M, Gore C, Swan T, Kamarulzaman A, DuCros P, Ford N. Viral hepatitis and the Global Burden of Disease: a need to regroup. Journal of viral hepatitis. 2013 Sep;20(9):600-1.
[16] Lauer GM. walker BD. Hepatitis C virus infection. N Eng1 J Med. 2001;345:41-52.
[17 ] He Y, Zhang J, Zhong L, Chen X, Liu HM, Wan LK, Wang H, Li H, Tian L, Hu JL, Luo P. Prevalence of and risk factors for hepatitis C virus infection among blood donors in Chengdu, China. Journal of medical virology. 2011 Apr;83(4):616-21.
[18] M Lemoine, S Eholie , K Lacombe. Reducing the neglected burden of viral hepatitis in Africa : strategies for a global approach . Journal of Hepatology. 2015, Oct 14;62 (2): 469,476.
[19] High KP, Marcus EL, Kaspa RT. Chronic Hepatitis C Virus Infection in Older Adults. Clinical Infectious Diseases. 2005 Dec 1; 41(11): 1606-1612.
[20] Atsbaha AH, Dejen TA, Belodu R, Getachew K, Saravanan M, Wasihun AG. Sero-prevalence and associated risk factors for hepatitis C virus infection among voluntary counseling testing and anti retroviral treatment clinic attendants in Adwa hospital, northern Ethiopia. BMC research Notes. 2016 Feb 23; 9:121.
[21] Abdel‐Aziz F, Habib M, Mohamed MK, Abdel‐Hamid M, Gamil F, Madkour S, Mikhail NN, Thomas D, Fix AD, Strickland GT, Anwar W. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology. 2000 Jul;32(1):111-5.
[22] Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015 Jan;61(1):77-87.
[23] Karoney MJ, Siika AM. Hepatitis C virus (HCV) infection in Africa: a review. Pan African medical journal. 2013 Jan 31 ;14(44): 44-44
[24] Lemoine M, Eholié S, Lacombe K. Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach. Journal of Hepatology. 2015 Feb 1;62(2):469-76.
[25] Luby S, Khanani R, Zia M et al. Evaluation of blood bank practices in Karachi, Pakistan, and the government's response. JPMA. The Journal of the Pakistan Medical Association. 2006 Jan;56(1 Suppl 1): S25.
[26] Siddiqui FA, Ehrinpreis MN, Janisse J, Dhar R, May E, Mutchnick MG. Demographics of a large cohort of urban chronic hepatitis C patients. Hepatology International. 2008 Sep 1;2(3):376-81.
[27] Ahmed W, Qureshi H, Arif A, Alam SE. Changing trend of viral hepatitis—" A twenty one year report from Pakistan Medical Research Council Research Centre, Jinnah Postgraduate Medical Centre, Karachi". JPMA. The Journal of the Pakistan Medical Association. 2010 Feb 1;60(2):86.
[28] Carithers Jr RL. Hepatitis C and renal failure. The American journal of medicine. 1999 Dec 27;107(6):90-4.
[29] Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc. 2002 Sep;52(9):398-402.
[30] Walsey A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis. 2000 ; 20(1): 01-16.
[31] Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis. 1995 Feb; 15(1):5-14.
[32] Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 2000;20(1):17-36.
[33] Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. International journal of infectious diseases. 2009 Jan 1;13(1):9-19.
[34] Ahmad J, Taj AS, Rahim A, Shah A, Rehman M. Frequency of Hepatitis B and Hepatitis C in healthy blood donors of NWFP: a single center experience. Journal of Postgraduate Medical Institute (Peshawar-Pakistan). 2004;18(3).
Published
2020-12-12
How to Cite
1.
Maheen M, Ruqia M, Fatima S. Risk Factors of Hepatitis C Virus Transmission. JRMC [Internet]. 12Dec.2020 [cited 8May2021];24(1):37-1. Available from: https://journalrmc.com/index.php/JRMC/article/view/1539